AshleyMachelleRoseMD(She/Her)

Hematology • Miami, FL

Hematologic Oncology

Physician

Join to view full profile

Dr. Rose is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rose's full profile

Already have an account?

Office
8932 SW 97th Ave
Ste 100
Miami, FL 33176
Phone+1 305-243-5302

Education & Training

University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2020 - 2023
University of South Florida MorsaniFellowship, Hospice and Palliative Medicine, 2019 - 2020
University of South Florida MorsaniResidency, Internal Medicine, 2016 - 2019
East Tennessee State University James H. Quillen College of MedicineClass of 2016

Certifications & Licensure

FL State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma.
Yumeng Zhang, Ashley Rose, Sushmita Khadka, Biwei Cao, Jennifer Eatrides
Transplantation and Cellular Therapy. 2024-09-01
3 citations
Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
Ashley Rose, Ling Zhang, Akriti G Jain, Abida Poovathukaran Babu, Lubomir Sokol
American Journal of Hematology. 2023-06-01
4 citations
Classical Hodgkin Lymphoma: Clinicopathologic Features, Prognostic Factors, and Outcomes From a 28-Year Single Institutional Experience.
Ashley Rose, Ariel F Grajales-Cruz, Alex Lim, Amber Todd, Celeste M. Bello
Clinical Lymphoma, Myeloma & Leukemia. 2021-02-01

Abstracts/Posters

Elotuzumab in Combination with an Immunomodulatory Agent (IMID) in Patients with Multiple Myeloma Refractory to Imids and/or Daratumumab: A Single-Institution Analysis...
Ashley Rose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Impact of Rituximab in the Clinical Outcomes of Hairy Cell Leukemia: A Retrospective Single-Institution Analysis
Ashley Rose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Authored Content

Connecting the Dots: A Case of Myeloid SarcomaMay 2018